MANGALAM DRUGS AND ORGANICS
Back to Income Statement
|
MANGALAM DRUGS AND ORGANICS Last 5 Year Revenue History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹451 Cr | ₹385 Cr | ₹282 Cr | ₹228 Cr | ₹279 Cr |
What is the latest Revenue of MANGALAM DRUGS AND ORGANICS ?
Year | Revenue |
---|---|
Mar2023 | ₹451 Cr |
Mar2022 | ₹385 Cr |
Mar2021 | ₹282 Cr |
Mar2020 | ₹228 Cr |
Mar2019 | ₹279 Cr |
How is Revenue of MANGALAM DRUGS AND ORGANICS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹451 Cr | 17.25 | |
Mar2022 | ₹385 Cr | 36.25 | |
Mar2021 | ₹282 Cr | 24.07 | |
Mar2020 | ₹228 Cr | -18.54 | |
Mar2019 | ₹279 Cr | - |
Compare Revenue of peers of MANGALAM DRUGS AND ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM DRUGS AND ORGANICS | ₹161.6 Cr | 1.5% | 10.4% | -10.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
MANGALAM DRUGS AND ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM DRUGS AND ORGANICS | 1.5% |
10.4% |
-10.9% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses